Profound Medical Corp. (PROF)
NASDAQ: PROF · IEX Real-Time Price · USD
8.03
+0.23 (2.95%)
At close: Apr 25, 2024, 3:57 PM
8.19
+0.16 (1.99%)
After-hours: Apr 25, 2024, 4:00 PM EDT
Profound Medical Market Cap
Profound Medical has a market cap or net worth of $196.16 million as of April 25, 2024. Its market cap has decreased by -17.37% in one year.
Market Cap
196.16M
Enterprise Value
186.01M
1-Year Change
-17.37%
Ranking
Category
Stock Price
$8.03
Market Cap Chart
Since October 30, 2019, Profound Medical's market cap has increased from $113.60M to $196.16M, an increase of 72.68%. That is a compound annual growth rate of 12.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 170.80M | 3.77% |
Apr 23, 2024 | 164.60M | -0.72% |
Apr 22, 2024 | 165.80M | 0.12% |
Apr 19, 2024 | 165.60M | -1.13% |
Apr 18, 2024 | 167.50M | 0.54% |
Apr 17, 2024 | 166.60M | -0.18% |
Apr 16, 2024 | 166.90M | -1.13% |
Apr 15, 2024 | 168.80M | -0.30% |
Apr 12, 2024 | 169.30M | -4.57% |
Apr 11, 2024 | 177.40M | 3.74% |
Apr 10, 2024 | 171.00M | -1.55% |
Apr 9, 2024 | 173.70M | -2.20% |
Apr 8, 2024 | 177.60M | 3.26% |
Apr 5, 2024 | 172.00M | -1.99% |
Apr 4, 2024 | 175.50M | -2.23% |
Apr 3, 2024 | 179.50M | -0.11% |
Apr 2, 2024 | 179.70M | 1.70% |
Apr 1, 2024 | 176.70M | -3.07% |
Mar 28, 2024 | 182.30M | 3.05% |
Mar 27, 2024 | 176.90M | 1.55% |
Mar 26, 2024 | 174.20M | 0.52% |
Mar 25, 2024 | 173.30M | -1.70% |
Mar 22, 2024 | 176.30M | -1.34% |
Mar 21, 2024 | 178.70M | -0.11% |
Mar 20, 2024 | 178.90M | 1.36% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Trevi Therapeutics | 196.54M |
Compass Therapeutics | 193.78M |
Innate Pharma | 191.60M |
Semler Scientific | 190.47M |
Acumen Pharmaceuticals | 189.85M |
Cellectis | 187.97M |
Alimera Sciences | 187.95M |
Akoya Biosciences | 187.23M |